New CRISPR-based gene therapy effectively targets cancer-causing 'fusion genes' and improves survival in mouse models of aggressive cancers, researchers report.

Source: Novel gene editing approach to cancer treatment shows promise in mice


David Cottle

UBB Owner & Administrator